Uma candidatura completa num minuto
Currículo e carta de apresentação personalizados, prontos a enviar.
Jodas Expoim Pvt. Ltd. in India is seeking an Analytical & CMC Lead to drive strategy and execution of characterization for mAbs and recombinant proteins.
You will oversee in house and outsourced methods, their development, qualification, tech transfer and validation, bridging R&D, manufacturing, and regulatory affairs to support global health authority filings. The role demands strong technical competency, precise documentation, and deep knowledge of ICH, FDA, and EMA guidelines.
The Analytical & CMC Lead drives the strategy and execution of physicochemical, structural, and functional characterization for monoclonal antibodies (mAbs) and other recombinant proteins. This role is directly responsible for in house and outsourced methods, their development, qualification, tech transfer and Validation. Additionally this role bridges R&D, manufacturing, and regulatory affairs to establish comprehensive data packages required for global health authority filings. The Person should have demonstrated technical competency, documentation skills, deep understanding of guidelines. Able to work under challenging environments, meet timelines and work towards cost effective strategies. Preferably, 10 years of experience with PhD or 15 years of experience with Masters.
Design and oversee comprehensive analytical similarity programs comparing the biosimilar candidate against the reference/innovator product across purity, potency, charge variants, and higher-order structures.
Lead the development, optimization, qualification, validation, and transfer of analytical methods (HPLC/UPLC, SEC, IEX, RP-HPLC, cIEF/icIEF, CE-SDS, LC-MS, and cell-based potency assays).
Identify and rank Critical Quality Attributes (CQAs), define process control strategies, and analyze forced degradation and stability study data.
Manage external testing laboratories, CMO/CDMO analytical deliverables, and cross-functional project teams.
Author and review analytical sections of regulatory dossiers, respond to health authority queries, and support GMP audits.
Investigate analytical deviations, out-of-specification (OOS) results, and root-cause analyses with corrective and preventive actions (CAPA).
Advanced chromatographic and electrophoretic methods (HPLC, UPLC, SEC, IEX, HIC, cIEF, CE-SDS).
Mass spectrometry (LC-MS) for primary structure and post-translational modification (PTM) analysis.
Biophysical characterization and cell-based potency/ELISA assays.
Deep familiarity with ICH, FDA, and EMA guidelines for biosimilars and quality risk management.